Department of Hematology, Changzheng Hospital, Second Hospital Affiliated to the Second Military Medical University, Shanghai 200003, China.
Chin Med J (Engl). 2010 Jun;123(11):1402-6.
Although neurologic manifestations often complicate the course of patients with multiple myeloma, direct central nervous system invasion is rare. This study explored the neurologic symptoms, signs, clinical features, therapy and prognosis of Chinese patients with central nervous system myeloma invasion.
The diagnosis, therapy and prognosis were analyzed retrospectively in 11 Chinese multiple myeloma patients with central nervous system infiltration from a total of 625 patients who have been treated at Changzheng Hospital (Shanghai, China) between January 1993 and May 2009. Survival curve was constructed with the use of Kaplan-Meier estimates.
There were 11 patients with central nervous system involvement from 625 multiple myeloma patients. The occurrence rate was 1.8%. Ten of the 11 patients had other extramedullary diseases. Symptoms included cerebral symptoms, cranial nerve palsies, and spinal cord or spinal nerve roots symptoms. Cerebrospinal fluid was abnormal in 7 patients, usually exhibiting pleocytosis and elevated protein content, plus positive cytologic findings. Specific magnetic resonance imaging findings suggestive of central nervous system invasion were found in 9 patients. After a median follow-up of 19 months, 3 patients were alive. The median overall survival for all patients was 23 months, while the median overall survival for patients after central nervous system invasion was merely 6 months.
It is exceedingly rare for there to be central nervous system infiltration in multiple myeloma patients. When it occurs, the prognosis is extremely poor despite the use of aggressive local and systemic treatment including stem cell transplantation.
尽管神经表现常使多发性骨髓瘤患者的病程复杂化,但直接侵犯中枢神经系统的情况较为少见。本研究探讨了中国中枢神经系统多发性骨髓瘤浸润患者的神经症状、体征、临床特征、治疗及预后。
回顾性分析 1993 年 1 月至 2009 年 5 月长征医院(中国上海)共 625 例多发性骨髓瘤患者中 11 例中枢神经系统浸润患者的诊断、治疗和预后。采用 Kaplan-Meier 估计法构建生存曲线。
625 例多发性骨髓瘤患者中有 11 例(1.8%)发生中枢神经系统受累。11 例患者中 10 例有其他髓外疾病。症状包括脑部症状、颅神经麻痹及脊髓或脊神经根症状。7 例患者脑脊液异常,通常表现为细胞增多和蛋白含量升高,同时细胞学检查阳性。9 例患者磁共振成像有提示中枢神经系统侵犯的特异性表现。中位随访 19 个月后,3 例患者存活。所有患者的中位总生存期为 23 个月,而中枢神经系统侵犯患者的中位总生存期仅为 6 个月。
多发性骨髓瘤患者中枢神经系统浸润极为罕见。尽管采用包括干细胞移植在内的积极局部和全身治疗,预后仍极差。